Drug
Darovasertib
Darovasertib: highest development phase Phase 3, developed by IDEAYA Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- IDEAYA Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Darovasertib NCT07804186 | Phase 3 | Uveal Melanoma |
Latest
No recent events.
Follow Darovasertib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.